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Migraine is a common disabling headache disorder characterized by recurrent episodes sometimes preceded
or accompanied by focal neurological symptoms called aura. The relation between two subtypes, migraine
without aura (MWoA) and migraine with aura (MWA), is explored with the aim to identify targets for
neuromodulation techniques. To this end, a dynamically regulated control system is schematically reduced
to a network of the trigeminal nerve, which innervates the cranial circulation, an associated descending
modulatory network of brainstem nuclei, and parasympathetic vasomotor efferents. This extends the idea of
a migraine generator region in the brainstem to a larger network and is still simple and explicit enough to
open up possibilities for mathematical modeling in the future. In this study, it is suggested that the migraine
generator network (MGN) is driven and may therefore respond differently to different spatio-temporal noxious
input in the migraine subtypes MWA and MWoA. The noxious input is caused by a cortical perturbation
of homeostasis, known as spreading depression (SD). The MGN might even trigger SD in the first place by
a failure in vasomotor control. As a consequence, migraine is considered as an inherently dynamical disease
to which a linear course from upstream to downstream events would not do justice. Minimally invasive and
noninvasive neuromodulation techniques are briefly reviewed and their rational is discussed in the context of
the proposed mechanism.
Migraine is characterized by recurrent attacks
of moderate to severe headaches sometimes pre-
ceded by visual, sensory, motor, or language dis-
turbances. These so-called migraine aura symp-
toms are caused by a chemical imbalance in the
brain that lasts usually not longer than one hour,
while the longer lasting headaches originate from
neural activity in the brainstem. Both have
been observed with non-invasive imaging. In
this study, it is proposed how these events are
linked together and that migraine pathophysiol-
ogy should be considered as a dynamical network
phenomenon.
I. INTRODUCTION
Migraine is one of the most prevalent neurological dis-
orders with a life-time prevalence of about 14%. Mi-
graines can cause substantial levels of disability, ranking
on a disability scale from 0.0-1.0 at 0.71. A migraine
attack can have up to four distinct stages: a prodromal
phase with difficulty concentrating, yawning, and fatigue;
an aura phase with all kinds of sensory disturbances; the
headache phase, often unilateral and throbbing; and fi-
nally a postdrome of tiredness, difficulty concentrating,
persistence of sensitivity to light and noise. Yet, despite
a distinctive clinical picture, migraine continues to be
underdiagnosed and undertreated. It is estimated that
the cost for the US and European economies sum up to
US$19.6 billion and e27 billion a year, respectively.
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There are several subforms of migraine, yet the two
main subtypes are migraine without aura (MWoA) and
migraine with aura (MWA). MWA comprises, for in-
stance, six subforms, one even without headache. While
for most migraine sufferers, the head pain is the key man-
ifestation of their disorder, the migraine aura is also a
distinctive feature: often visual hallucinations, language
problems, motor weakness and other short-duration (5-
60min) changes to sensory modalities or cognitive func-
tions. These symptoms occur only in MWA, i.e., in about
30% of the cases and usually precede or sometimes ac-
company the headache2. Why not in all attacks? This
raises a related more general question: Is the pain mech-
anism in MWoA and MWA the same? If so, what drives
the activation of neuronal pain pathways and how is this
related to the cause of aura symptoms? And what de-
termines which sensory modality or cognitive function
is affected? These interlinked questions about migraine
pathophysiology remain open or are only unsatisfactorily
answered in current migraine theories.
The migraine generator and the spreading depression
(SD) theory of migraine both focus on distinct patho-
physiologic events, yet they are not mutually exclusive
theories of the cause of episodic migraine. The issues
raised above might be resolved, if both theories can be
unified.
From a mathematical point of view, migraine patho-
physiology involves sudden dynamical transitions, be-
cause although migraine is a chronic neurological disor-
der it is characterized by recurrent episodes. In these
transitions both temporal rhythms and spatio-temporal
patterns change, which allows only one conclusion: mi-
graine is a dynamical disease; a term coined to identify
diseases that occur due to an abrupt change, usually a
bifurcation. In fact originally, dynamical diseases are de-
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2fined as a situation where sudden changes bring the sys-
tem through a bifurcation3. But in a wider sense, if we
have—or aim for—an understanding of the pathophysi-
ological mechanism in terms of equations of motion and
low dimensional phase space structures, we may call it
a dynamical disease. The sudden change may also origi-
nate from other dynamical phenomena than bifurcations,
such as intermittency, noise driven excitation behavior,
etc.. These various points that lead to sudden transitions
may also be summarized as “tipping points”.
As a consequence, migraine pathophysiology needs to
be considered as a problem at the interface of clinical
neurology and applied nonlinear science. To this end,
the migraine generator theory must be extended from a
theory of brainstem regions as the origin of attacks to
a network concept where the origin is not localized but
a dynamical transition into dysfunctional control4–7. In
Sec. II, an extended but still reduced migraine genera-
tor network (MGN) will be introduced. This network
is connected to the cortex, where the spatio-temporal
patterns of SD occur. SD itself can be describes by a
macroscopic continuous limit of cortical tissue in terms
of reaction-diffusion systems (Sec. III). How do these two
dynamical systems interact in migraine, that is, how is
the central pattern generator network coupled to the cor-
tical reaction-diffusion system?
A possible relation is proposed in this theoretical study.
The pivotal role lies in the driving input of the MGN.
The MGN is a system that compromises two physiologi-
cal control subsystems, the trigeminovascular system for
vasomotor control and associated descending modulatory
brainstem system for pain control. The vasomotor sys-
tem may even lead to the ignition of cortical SD in the
first place, which then in turn drives the MGN. We do
not consider the cause of the ignition of SD but suggest
SD—once ignited—drives the MGN and this systems re-
sponds differently to different spatio-temporal signatures
of SD, that is, characteristic noxious action of SD leads
to the subforms MWA and MWoA. In this study, only
the driving mechanism is considered in some detail in
Sec. III.
A mathematical model of this dynamical response is
beyond the scope here, though the MGN itself is pre-
sented as a reduced scheme explicit enough to support the
conclusions for neuromodulation techniques (Sec. IV). In
general, this dynamical response is a form of central sensi-
tization, which refers to a transition in a pain network—
part of the central nervous system—after which it re-
sponds with increased sensitivity to noxious stimuli (hy-
peralgesia) and even non-noxious stimuli (allodynia). In
episodic migraine, the central sensitization is probably
one of second-order neurons8. Chronic migraine, in con-
trast, central sensitization is probably a dynamical tran-
sition in the pain matrix (see below), which also leads
to an enhanced response to peripheral input but is not
considered here.
In Sec. IV, minimally invasive and noninvasive neuro-
modulation techniques are briefly reviewed. These tech-
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FIG. 1. (color online) Networks related to pain. (a) Cra-
nial circulation (CC): connected by first-order perivascular
pain-sensitive neurons via the trigenimal ganglion (TG) to
the trigeminocervical complex (TCC, see b) and receives also
input from the superior salivatory nucleus (SSN). (b) Brain-
stem: trigeminal ganglion (TG); trigeminal nucleus caudalis
(TNC) and C1-C2 regions compromise the trigeminocervi-
cal complex (TCC); rostral ventromedial medulla (RVM),
locus coeruleus (LC), ventrolateral periaqueductal grey (vl-
PAG). (c) Pain matrix62: thalamus (TH); anterior cingulate
cortex (ACC); amygdala (Amyg); (PFC); primary (S1) and
secondary (S2) somatosensory cortices; supplementary motor
area (SMA); prefrontal cortex (PPC); insula cortex (Insula).
niques target neural structures in the peripheral and cen-
tral nervous system that have been introduced in Sec. II
and Sec. III. The aim of these techniques is to abort
migraine. I discuss their rational in the context of the
proposed driving mechanism of the MGN by SD dynam-
ics.
In conclusion, noninvasive techniques for episodic mi-
graine should be most effective in transcranial stimula-
tion with three distinct modes of action, for (i) the pro-
dromal phase, (ii) the ignition and (iii) the acute phase
of migraine aura. Furthermore, one mode of action in
transcutaneous stimulation (iv) in the acute pain phase
of the episodic attacks. Further quantitative approaches
are needed to find optimized stimulation protocols for
these situations based on the proposed mechanism.
II. MIGRAINE GENERATOR NETWORK
In several respects, pain is different from other sen-
sations. For instance, normal sensory pathways take a
chain of three neurons to get from receptors, e.g., sen-
sitive mechanoreceptors, to the primary sensory cortical
area. In pain traffic, there are more intermediate nuclei
and a cascade of descending control mechanisms is essen-
tial for defining the pain experience9. Therefore a simple
order of neurons on the way to the cortex is questionable.
Furthermore, instead of a single, i. e., spatially confined,
primary cortical area as the first target in the cortex,
a neural correlate of pain perception seems to be found
in spatially segregated activity patterns of a widespread
network of cortical areas.
Whether there is a network specific for pain percep-
tion, the “pain matrix”—a term that usually also in-
3cludes diencephalic structures in the forebrain such as
the thalamus, see Fig. 1—or not and instead this net-
work actually is a largely unspecific sensory “neuroma-
trix”, is still debated10. In any case, this matrix seems
not to be an optimal target in episodic migraine treat-
ment, e.g., for neuromodulation techniques, because its
activity patterns are probably truly downstream events
(but cf. chronification of pain, i. e., >15 headache days
per month over a 3 month period, at least 8 migrainous,
and absence of medication overuse).
The question of the most upstream event is more diffi-
cult (see Discussion), and it may only make sense to talk
about upstream events in the form of transitions in dy-
namical states of the migraine generator and spreading
depression (Sec. III).
While it is worth illustrating all nuclei of this network
in their respective anatomical place (in approximation),
it is still necessary to identify a schematically reduced
network of these nuclei, their neural subpopulations, and
a vasomotor loop that is explicit enough to convey the
regulatory control in this network structure amenable for
mathematical analysis, see Fig. 2. For this reason, the
following brain regions and their respective functions are
briefly introduced.
A. The trigeminovascular system
The trigeminovascular system, which is key to under-
standing the network structure of the MGN, is a largely
bidirectional system. Notwithstanding, it is natural to
consider as a starting point, if only for convenience, the
nociceptor and the afferent projection of the first-order
neuron, that is, the innervation of both dura mater and
large intracranial vessels by the ophthalmic division of
the trigeminal nerve. This innervation of the cranial cir-
culation (CC) terminates in the central trigeminal nu-
cleus caudalis (TNC) and the C1-C2 regions of the cervi-
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FIG. 2. (color online) Schematic diagram of pathways in the
migraine generator network (MGN)14,15,63.
cal spinal cord, together known as the trigeminocervical
complex (TCC), see Fig. 1.
Beyond the TCC, nociceptive traffic ascends by acti-
vated second-order neurons to further brainstem nuclei:
the rostral ventromedial medulla (RVM) including the
nucleus raphe magnus (NRM) in the medulla; the lo-
cus coeruleus (LC) in the dorsolateral pons (both hind-
brain); and the ventrolateral periaqueductal grey (vl-
PAG) in the tegmentum (midbrain). Furthermore, the
TCC also ascends nociceptive information directly to the
hypothalamus (HY) and thalamus (TH) with second-
order neurons along the trigeminohypothalamic tract and
the trigeminothalamic tract (also know as quintothalamic
tract), respectively. TH and HY are structures in the di-
encephalon of the forebrain from where third-order neu-
rons ascend to the cortex (CTX), the final telencephalic
station within the forebrain.
For the sake of completeness, one other pathway of the
trigeminovascular systems should be mentioned. There
is a peripheral vasomotor connection from efferents of the
superior cervical spinal cord to the cranial circulation11.
B. Cortical and diencephalic influence
Before we come to the descending modulatory network
of the brainstem, let us briefly mention descending path-
ways from the pain matrix. Cortical projections to the
periaqueductal grey (PAG) arise from the medial network
of the prefrontal cortex (PFC) or cortical areas that are
closely related to this network12. The interest here is
obviously the part which belongs to the MGN, in partic-
ular the ventrolateral (vl) PAG. The vlPAG evokes pas-
sive coping reactions (withdrawal, quiescence)13 consis-
tent with behavior exhibited by migraine patients. Since
such coping behavior is also readily elicited in animals
with the forebrain being disconnected from the brain
stem13, a less important role of these descending path-
ways for the dynamics of the MGN is expected.
Therefore, we do not include the detailed areas or even
a closed feedback loop through the pain matrix in the
attempt to construct a basic structure of the MGN in
Fig. 2, though this input is indicated by a dotted grey
arrow. To support this further, it could be shown with
non-invasive imaging that brainstem activation in hu-
mans persists in migraine even after pain relief and re-
duction of symptoms by acute treatment4. However, it
might be that not PAG but nearby nuclei in the dorso-
lateral pons are causing the activation7.
Notwithstanding, the thalamus is certainly key for
integration of nociceptive inputs in migraine and the
pain matrix for pain sensation14. In particular to un-
derstand chronification of pain, closed feedback loops
through these areas are probably important and these
diencephalic or cortical areas may even primarily be the
“upstream” target areas for a therapeutic rational in
chronic migraine.
4C. Descending modulatory network
Given that PAG is an area to which various cortical
and diencephalic structures project, it is important to
note that PAG does not directly project itself to the
TCC. The descending projection from PAG modulate
ON and OFF neurons in RVM. As indicated by the name,
these ON and OFF neurons in the PAG-RVM descending
control system can be facilitatory and inhibitory depend-
ing on how the balance shifts in either direction15. A
descending facilitation of TCC can provide a mechanism
for central sensitisation. The development of cutaneous
allodynia suggests that the balance shifts in favor of fa-
cilitation explaining the increased sensitivity of the skin
to non-noxious stimuli in migraine16.
It has been questioned whether the PAG or rather the
nuclei in the dorsolateral pons, like LC, are responsible
in this descending modulatory network and it was sug-
gested that “[t]o advance the brainstem migraine gen-
erator theory from the opinion phase to being evidence
based, answers should be provided to questions as: (a)
How would increased activation in the PAG drive or pro-
duce migraine?”7. Quantitative approaches in a form of
a mathematical model similar to the gate theory of first-
order neurons17 may contribute to this question. The
important notion stressed here is that the extended mi-
graine generator network theory is essentially a dynamic
network theory. The MGN is a central pattern gener-
ator, that is, a neural network that produces rhythmic
patterned output perceived as pain without sensory feed-
back. However, such feedback is still needed, as proposed
here, to drive the transition into central sensitization.
The explanatory power of a mathematical approach lies
in the predictive power, but it certainly also needs the
clinical testing to be evidence based.
D. Vasomotor control
The key vasomotor control is probably played by a
parasympathetic cluster of neuronal cell bodies located
in a fossa (ditch) in the skull, the sphenopalatine
ganglion (SPG). The simplest putative structure of the
MGN (Fig. 2) is completed by the SPG and its second-
order preganglionic neurons in the superior salivatory
nucleus (SSN). It was suggested that migraine triggers
typical for the prodromal phase either activate or even
originate in a number of brain areas whose projections
converge on the SSN (dotted grey arrow) and which are
functionally positioned to produce migraine symptoms8.
III. SPREADING DEPRESSION THEORY OF
MIGRAINE
SD is essentially a slow (about 3mm/min = 50µm/sec)
reaction-diffusion wave in gray matter tissue. In the cor-
tex, SD is accompanied by a pronounced hemodynamic
response of increased regional cerebral blood flow (hyper-
mia) for about 2min and a long lasting, ∼2h, decrease
(oligemia)18.
The cortical tissue SD traverses is massively perturbed
in its ion homeostasis19. If the ion flow across the mem-
brane in this region is taken to estimate relative changes
in Gibbs free energy of the tissue, SD reveals itself as
“a twilight state close to death”20, i. e., during the peak
of SD the cortical state is similar to the one in stroke
or ischemia. The ion flow causing this state is far more
dramatic than in any other neurological disorders, for in-
stance, compared to the ion flow during ictal epileptic
activity.
However, the cortex is not pain sensitive. It was
therefore suggested that SD may trigger the pain phase
indirectly21,22.
A. SD and pain pathways
In several animal models, possible pathways were in-
vestigated to see how SD might cause pain by activating
nociceptors in sensitive intracranial tissues and subse-
quently activate the TCC23. In short, it was suggested
that during SD the blood–brain barrier becomes more
permeable, allowing glutamate, potassium ions, hydro-
gen ions, nitric oxide and other noxious substances or in-
flammatory mediators to diffuse from the surface of the
cortex into the meninges where they activate nocicep-
tors of the cranial circulation. Although this mechanism
has been criticized24, the animal models of migraine show
that SD activates the first-order neurons in the trigeminal
nucleus caudalis21,22,25,26. In a newly published article,
it was found that SD can trigger headache by activating
neuronal Panx1 channels, a megachannel that is a struc-
tural component of gap junctions27. It is furthermore
discussed, whether nuclei in the MGN in turn can cause
spreading depression in the cortex. For a summary, see
Ref.28.
B. SD, aura, and silent courses
Even the apparently solved question of how SD relates
to the aura phase has still some merit. It is clear that the
aura is caused by SD. At least after successfully imaging
the blood flow in migraine aura, it became indisputable
that SD is the electrophysiological correlate of migraine
aura29–31. In fact, already in 1945, Lea˜o wrote: “The lat-
ter disease [migraine] with the marked dilatation of major
blood vessels and the slow march of scotomata [sensory
blindness] in the visual or somatic sensory sphere is sug-
gestively similar to the experimental phenomenon here
described [SD], in spite of the fact that known scotomata
are still felt to be vasoconstrictor in nature”32. It was
not known in 1945 that in migraine, a vasoconstrictor
response (oligemia) is also present.
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FIG. 3. (color online) Paradigms of SD pattern in migraine.
Narrow band of excitation (red), refractory zone (yellow),
disperse neurovascular feedback (green). (a) Typical text-
book illustration: SD engulfing large parts of one hemisphere;
adopted from Ref.30. (b) Localized SD wave in a full-scale
attack31,36.
To date, what remains disputed is whether SD is even
present but clinically silent in the migraine subtype
MWoA. This is referred to by the contested notion of
“silent aura”28. If true, it is SD which stays silent, the
aura is simply not present. Therefore “silent SD” is a
term less perplexing. Anyway, such silent SD courses are
supported by (a) a well-documented case of blood-flow
changes that were likely the result of SD observed in a
spontaneous migraine headache without aura33 and (b)
the fact that SD can cause pain and MWA and MWoA
are likely to share the same pain mechanism.
To resolve these questions about the relation of SD
to the pain and aura phase, we recently suggested that
which of the two migraine subtypes develops, i. e., MWoA
or MWA, is dependent upon the spatio-temporal pattern
(shape, size, and duration) of SD34. This does not rule
out the possibility that SD itself is triggered by events
in the brainstem and therefore we contribute only little
to the questions of the most upstream event. However,
the crucial part missed in the current controversy might
be the spatio-temporal pattern of the cortical tissue be-
ing recruited into a depleted state. All too often, it is
completely ignored that SD usually propagates in the
human gyrified cortex as a discontinuous wave segment
as observed with fMRI in migraine and reported by pa-
tients as visual field defects31,35,36, see Fig. 3b. In ani-
mal models, SD is engulfing the whole lissencephalic cere-
bral hemisphere but already in gyrencephalic cat brain
only the first SD waves do this and succeeding secondary
SD waves, which propagate in relative refractory, i. e.,
less susceptible, cortex, often remained within a confined
origin37.
C. Localized SD waves
Both fMRI data and reports on visual field
defects31,35,36 clearly show that SD is not only spatially
confined in humans, but SD is a discontinuous wave—a
particle-like wave. A particle-like wave is a wave front
with two open ends, sometimes also called dissipative
soliton38. The existence of such localized waves is a
change in the pattern forming paradigm indicating a fast
diffusing second inhibitor related to the Turing bifurca-
tion.
From a clinical perspective, migraine aura symptoms
are focal symptoms. If SD were to spread out in all di-
rections, the affected cortical area would increase quickly
and symptoms should become more generalized. Local-
ization does not merely restrict the symptoms caused by
SD; but localization also allows SD to assume a much
larger variety of spatio-temporal patterns compared to a
continuous circular wave front. This is reflected in the va-
riety of the courses of focal aura symptoms39 and maybe
also in the fact that SD could stay silent under certain
conditions on the localised pattern (Sec. III B,F) and,
furthermore, that SD does not cause pain under other
conditions (Sec. III F-G).
For these reasons, it is an essential feature that SD
stays localised even when it propagates a long distance
in one direction. In contrast, if SD spread out in all
directions, as to date shown in all modern migraine text-
books (published or revised in the last 5 years), the shape
would essentially be circular (cortical folding has some in-
fluence) and, furthermore, size and duration both would
depend on a single parameter, the radial distance SD
travels. The course that is usually sketched starts from
the occipital pole of the cortex and SD propagates in
a full-scale MWA attack up until the frontal lobe, see
Fig. 3a. If SD invaded the complete occipital, temporal,
and parietal lobe, this would not match with the reported
courses of neurological symptoms during the aura phase,
not even in a full-scale attack, cf. Ref.39, and it is also
implausible that only a subset of the nearly completely
depleted cortical tissue results in some form of clinical
manifestation.
A simple calculation illustrates the different scaling be-
havior of events. In a full-scale MWA attack, the aura
phase can last up to one hour. This corresponds to
a length l of l1 = 18cm cortex being paced. Even if
we halve this distance l2 = 9cm— either because SD
is slower or lasting only 30min and symptoms reverber-
ate for a full 60min—this would still correspond to 20%
(80% for l1 = 18cm) of the surface area of one cerebral
hemisphere. In contrast, only 1.5% (3% for l1 = 18cm)
of the surface are affected in a full-scale MWA, if the
particle-like SD wave is on average 2cm wide. Note that
the progressive development of aura symptoms is, except
for the ignition phase of SD, probably mostly due to the
fact that SD starts in regions of high cortical sensory
magnification and travels into regions with lower cortical
magnification40.
6D. Generic reaction-diffusion model
In accordance with the noninvasively imaged SD pro-
gression and reported visual field defects, we proposed
a model in which in each attack a particular pattern is
formed by a discontinuous wave segment that spreads
out only in one direction determined by the initial
conditions34 and guided by the folding pattern (unpub-
lished results). The ignition patterns that trigger these
simulated attacks are given by an assumed hyperactiv-
ity in a cortical feature map of the visual cortex used as
initial conditions for the model. These feature map pat-
terns were also suggested to be hyperactive during SD
causing visual hallucinatory percepts41.
In this generic reaction-diffusion mechanism of ex-
citable media, the resulting pattern forming processes
following these initial conditions are described in ab-
stract terms of activator-inhibitor kinetics of two vari-
ables u and v, respectively. In fact, simple activator ki-
netics of u date back to a mechanism of SD described in
1963 by Grafstein, Hodgkin and Huxley (GHH)42. The
GHH model assumed u ≡ [K+]e, i. e., the extracellular
potassium ion concentration to be the activator u. We
extended this scheme (for details of the full model see
Ref.34):
∂u
∂t
= u− 1
3
u3 − v +D∇2u, (1)
∂v
∂t
= ε
(
u+ β +K
∫
H (u) dxdy
)
, (2)
with D the diffusion coefficient, two parameters ε (time
scale separation) and β (threshold), H being the Heav-
iside step function (discontinuous function whose value
for negative (positive) arguments is 0 (1) and 0.5 for the
argument zero). The integral term is therefore a surface
area measure of the medium being in a state with u larger
than zero that can globally increase the threshold.
Both activator u and inhibitor v are lump variables.
Unlike in the original GHH model, it is not necessary or
even possible to identify particular physiological quan-
tities, like [K+]e, with them. Instead, the activator u
should be viewed as the bistable energy state. One stable
fixed point corresponds to the maintenance of homeosta-
sis far from thermodynamic equilibrium and the other
stable fixed point to the state where the cellular Nernst
reversal potential are depleted (thermodynamic equilib-
rium). In the presence of an inhibitor v, which was not
included in the GHH model, the second stable fixed point
becomes a transient state. In other words, the inhibitor
v is a recovery variable. It is related to ion pumps that
drive the tissue far from thermodynamic equilibrium and
(re)charge Nernst reversal potentials. We set the parame-
ters as follows: time scale separation ε = 0.04, the thresh-
old β = 1.32, and the mean field coupling K = 0.003.
The details of the model are discussed elsewhere34,35.
In short, for K = 0, the bistable activator kinetics
with diffusion and the linear inhibitor kinetics (immo-
bilised) provide the simplest reaction-diffusion model of
activator-inhibitor type for the cortex as an excitable
media exhibiting patterns as seen during SD in animal
models. The homogeneous steady state is a stable so-
lution representing the healthy cortical state. A critical
neuronal mass is needed to start ignition and support
sustained propagation of a Gibbs free energy–depleted
state, which is associated with the state of SD20. For
K = 0, this depleted SD state would engulf all the tissue
after an initial ignition. The suggested pattern forming
mechanism of localized SD is closely related to the criti-
cal mass needed for ignition, called a critical nucleation
solution, see Fig. 4a.
This critical nucleation is controlled for K 6= 0 by a
widely spread out inhibitory feedback, Fig. 4b,c. This
inhibitory feedback is approximated by a mean field term
K
∫
H (u) dxdy, a term proportional to the depleted sur-
face area region in the cortex. The physiological signifi-
cance of this last term in the rate function of the lump
variable v is associated with the neurovascular feedback
(e.g., as observed during hypermia of increased blood
flow29,31) in SD. For the sake of simplicity, we chose it to
be proportional to the surface area of the depleted state,
although the neurovascular feedback is mainly driven by
the neuronal hyperactivity in the rise of the SD front.
Therefore, a measure that is proportional to the length
of the SD front may be more appropriate. However, we
tested K
∫
H (u)H (1− v) dxdy, which is an approxi-
mated measure of the length of the SD front—the ac-
tivator must be in the excited state while the inhibitor
is still low, as characteristic for the hyperactivity in the
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FIG. 4. (color online) Schematic orbit structures in phase
space34, see text. (a) Caricature of excitable media. (b) Basin
of attraction change when local excitabilty parameter change.
(c) Fast secondary inhibition creates localized structures. (d)
Ghost behaviour when traveling wave solution (node) collides
with nucleation (saddle): the two trajectories are associated
with migraine with aura (MWA) and with migraine with typ-
ical aura without headache (MxWA). (e) Direction of cortical
area affected by SD. (f) Trajectory of a circular wave associ-
ated with migraine without aura (MWoA).
7rising front—with similar results.
E. Transient waves and slow dynamics
Changing a parameter of this model without the mean
field inhibitory feedback (K = 0), essentially varies the
basins of attraction of the existing solutions, e. g., mak-
ing the medium less susceptible by increasing the basin
of attraction of the homogeneous steady state, Fig. 4b.
For K 6= 0, the traveling wave solution itself is changed
such that the traveling wave solution becomes localized,
as described in the previous section, Fig. 4c. For suf-
ficiently large K, this stable localized solution collides
with its nucleation solution (saddle), which leads to well
known phenomenon of slow dynamics named ghost be-
havior after a saddle-node bifurcation, Fig. 4d. This is
the origin of the transient nature of the SD signatures in
Fig. 5 that we propose to lead to migraine without aura,
migraine with aura, and migraine with typical aura and
without headache (MWoA, MWA, and MxWA, respec-
tively).
In particular, MWA, and MxWA correspond to trajec-
tories that pass the ghost of the slow manifold (lightblue
in Fig. 4d). In contrast, solutions that are shorter lasting
but with larger MIA (cf. Fig. 4e) do not pass the ghost
of the slow manifold Fig. 4f; they correspond to MWoA.
In Sec. IV D, this is further discussed in the context of
the therapeutic strategy for neuromodulation.
The macroscopic features of SD are well described by
this model. The affected cortical area will not grow in
time and SD stays localized while propagating (for fur-
ther discussion of the usefulness of such a toy model, see
Sec. IV D). It is worth noting that it is not without irony
that both terms in the name of SD are rather misleading:
the important neural activity is a hyperactivity that only
in the depleted phase becomes “depressed”, and this cor-
tical state is only in the ignition phase “spreading”, the
sustained main process is a traveling wave.
F. Link to migraine subforms
We performed statistical analysis of the spatio-
temporal development governed by the generic reaction-
diffusion model in Eq. (1)-(2) that followed 8000 different
natural initial perturbations of local hyperactivity as SD
triggers. These perturbations were introduced by an in-
crease of the resting value of u. Based on that, we predict
that certain features related to shape, size, and duration
of SD (Fig. 5a) determine the aura phase while others
determine the pain phase in migraine.
It is important for further discussion that we firstly
divide the subtype MWA into its two subforms “typi-
cal aura with migraine headache (1.2.1, in the interna-
tional classification)” and “typical aura without headache
(1.2.3)”, which we refer to as MxWA. Therefore, in the
remainder of the text, we refer to 1.2.1 as MWA, i.e.,
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FIG. 5. (color online) (a) Spatio-temporal signatures of SD as
obtained from a reaction-diffusion model with mean field cou-
pling, Eqs. (1)-(2); cf. Fig. 4E in Ref.31. The model param-
eters are chosen such that only transient waves exist34, note
that we have scaled the dimensionless model such that the
units of time are roughly corresponding to minutes, and sur-
face area to cm2 and the wave spreads with about 3mm/min.
Four stereotypical courses are depicted following a local per-
turbation of a homogeneous steady state: (1) subthreshold,
SD dies out quickly without initial spread; (2) superthresh-
old perturbation, SD dies out after a few minutes, if its front
does not break open, corresponding to migraine without aura
(MWoA); (3)-(4) superthreshold perturbation, SD propagates
for up to 30min (∼15 in (3), ∼25min in (4)), if the SD front
breaks open, corresponding to migraine with aura (MWA).
(b) Statistical analysis of 8000 events plotted over MIA and
TAA, see text.
we explicitly assume the presence of headache. MxWA
is estimated to account for about 5% and MWA for 25%
of the 30% of the subtype migraine with aura (1.2). The
number of unreported cases of MxWA might be quite
large, though.
Together with MWoA, three combinations exist. We
predict that each migraine subform has a specific sig-
nature of SD. Characteristic for this signature is not
only the spatio-temporal pattern of the course of SD in
the gyrified human cortex but also the hemodynamic re-
sponse and the amount of noxious substances that diffuse
into the meninges. The cortical folding pattern should
also influence this signature. We are currently perform-
ing a detailed analysis of this influence.
In particular, we predict that a sufficiently large sur-
face area must be instantaneously affected and thus de-
pleted by SD to lead into the pain phase in migraine.
Therefore, we propose that if the maximal instanta-
neously affected area (MIA, Fig. 5b) is too small, the
cascade of subsequent events causing sustained activa-
tion of trigeminal afferents is not initiated. The ratio-
nal behind this is that the transmission of substances
(noxious or inflammatory mediators) in the direction per-
pendicular to the cortical surface into the pain sensitive
meninges should be significantly convergent to reach nox-
ious threshold concentration and initiate central sensiti-
sation of second order neurons, Fig. 6. While the flow
driven by small MIA is sufficiently diluted and therefore
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FIG. 6. (color online) Schematic representation of a corti-
cal cross section with meninges and skull. Top: large MIA;
bottom: lower MIA, not to scale; cortical thickness is at the
occipital lobe about 2mm; diameter of MIA pain threshold is
approximately 1.78cm.
tolerated. This makes a prediction that can be tested by
noninvasive imaging.
Furthermore, only if SD assumes a spatio-temporal
form that is lasting long enough (>5min) and therefore
also propagating farther (>1.5cm), SD will cause notice-
ably aura symptoms. In fact, this is not a prediction.
It merely reflects the diagnostic criteria of migraine aura
given by the International Classification of Headache Dis-
orders: “focal neurological symptoms that usually de-
velop gradually over 5-20 minutes”. So any neurological
events that last less than 5min are usually not diagnosed
as migraine aura.
The pain phase is completely suppressed in cases of
MxWA, if the ignition is not causing a large MIA.
Such a temporal evolution in Eq. (1)-(2) is expected for
initial perturbations that are just large enough to be
suprathreshold stimulations and at the same time are
asymmetric to lead directly into a discontinuous wave
(Fig. 4D) that is slowed down. As a consequence from
the model, MxWA are particularly long lasting auras,
again a prediction that can be tested.
G. Pain threshold determined by SD reaction-diffusion
model
The distribution of spatio-temporal SD patterns that
results from local perturbation led us to suggest a pain
threshold determined by MIA. This value can be esti-
mated to be about MIA≈ 2.5cm2. In other words, if SD
is never depleting the transmembrane gradients in cor-
tical tissue over a surface area of more than 2.5cm2 (at
any given time), the pain cascade is not initiated. This
corresponds to a circular area with a diameter of about
d ≈ 1.78cm or 0.1% of the total cortical surface. The
course (2) shown in Fig. 5 has a MIA of about 4.6cm2,
while the course (3) and (4) are just above the pain
threshold.
In a nondimensionalized generic model, we can only
give an estimate of the surface area of the pain threshold.
In fact, we rely on some self-consistency which can have
biased the result as discussed briefly in the following.
To estimate surface area in units of cm2, the nondimen-
sionalization of the SD model needs to be considered. We
could have started with bistable kinetics for the activa-
tor, similar to that as suggested in the GHH model for
u = [K+]e with three roots at 3mM and 55mM, for the
stable fixed points, resting state and depleted state, re-
spectively, and 10mM for the threshold, a value that is
under physiological conditions well preserved and there-
fore called the ceiling level of [K+]e
43. Also the diffusion
coefficient for potassium ions in the brain can be used.
This would result in an equation structurally similar to
Eq. (1) but in a dimensionalized form. If we were to add
linear kinetics for an immobilized inhibitor (for the sake
of argument, set in Eq. (2) K = 0), there is a total of 7
parameters (4 for the cubic rate function of u, the diffu-
sion coefficient, and 2 for the linear rate function of v).
We can scale 4 quantities : the 2 concentrations of u and
v as well as time and space. Therefore, only 3 free pa-
rameters remain in a nondimensionalized model. Since
the rate function in Eq. (2) (still with K = 0) is only a
function of u and not also v, this reduces further to the
two parameter β and ε—for the weak limit, we consider
here, this is canonical. Weak limit refers to the fact that
the threshold of the local dynamics (D = 0) is large and
the bifurcation that determines the oscillatory behavior
(type I or type II) is irrelevant.
For any set (ε, β) in the parameter plane, we can re-
construct dimensionalized space and time scales, because
we know both the speed of SD and the width of the wave
profile44. This procedure can be performed in a similar
way with K 6= 0, although we select by the choice of the
mean field feedback the size of the critical surface area.
This is because the choice of K selects a specific path
in parameter space through the saddle-node bifurcation
and therefore also the “ghost” behavior, which is indi-
rectly linked to the obtained value of the pain threshold,
see Ref.34 for a detailed discussion. For the values used
here, we have approximated the dimensionalized time
and space scales td and xd (and yd) by td = t/10 and
xd = x/8, where t and x are nondimensionalized time
and space scales from Eqs. (1)-(2), respectively.
9IV. DYNAMICAL DISEASE AND
NEUROMODULATION
It is often not helpful or even meaningful to talk about
an upstream cause for a composite dynamical system be-
ing out of control, if the control is established in closed
loop feedback between the composites. It is likely that
migraine episodes are caused by events that should be de-
scribed as transitions in the dynamical state of the brain.
And it can take various triggers to make this transition
but the cause is inherently in the dynamics. Therefore,
let us address the question: Why do we want to under-
stand migraine as a dynamical disease?
“The significance of identifying a dynamical disease is
that it should be possible to develop therapeutic strate-
gies based on our understanding of dynamics combined
with manipulations of the physiological parameters back
into the normal ranges”45. This quote provides a general
answer to this question and to why therapeutic strate-
gies that rely on the dynamics will be considered in this
section.
The focus in this study is on neuromodulation tech-
niques. One reason is because pharmacological treat-
ment is not suitable for any direct dynamical treatment
at high frequencies because most fast time scales are
damped due to pharmacokinetics, that is, absorption,
distribution, and metabolism, before pharmacodynam-
ics sets in—which of course can act indirectly on fast
time scales. These issues are bypassed in neuromodula-
tion. Neuromodulation is also usually (though not al-
ways, see below) spatially confined. Since dynamical dis-
eases are caused by transitions in both temporal rhythms
and spatio-temporal patterns, neuromodulation is the
natural ansatz for their treatment. “The headache future
is bright for neuromodulation techniques, if we manage
to understand how they work.” A quote from a slide by
Jan Schoenen (with permission).
Another reason is that various minimally invasive and
noninvasive neuromodulation techniques are available
and have been tested clinically in migraine46. To date,
these treatment options are usually only considered in
migraine in chronic cases of several disabling attacks per
month that are refractory to other current treatment.
But they might become available in episodic migraine, if
safety issues are appropriately resolved.
A. Phase-dependent mode of action
Possible target regions are the brain structures de-
picted in Fig. 2. At least two distinct dynamical situ-
ations during a migraine episode should be distinguished
because the optimal stimulation protocol is likely to de-
pend not only on the mode of action but also on these dif-
ferent phases. The ignition phase (IP, Fig. 8a) where SD
is actively controlled by hyperemia, and the longer last-
ing acute phase (AP, Fig. 8b), including oligemia (∼ 2h)
and sustained pain activity, which can last in migraine
from 4 to 72h.
The IP lasts about as long as SD circumscribes a large
surface area in the cortical tissue, which is assumed to
be above the pain threshold, Fig. 7. During the acute
aura phase, there is a cortical spatio-temporal pattern
of both hyperemia and oligemia related to the SD pat-
tern. This pattern might project even to the nuclei of
the MGN, that is, it is mapped in a topographic repre-
sentation. The acute pain phase can overlap and last up
to 72h. Therefore Fig. 8 oversimplifies these phases but
gives a first hint on the dominant dynamics. In partic-
ular, Fig. 8a shows the traffic that eventually results in
central sensitization, while Fig. 8b shows the facilitated
pain traffic during central sensitization (cf. Sec. II). As
a consequence, different neuromodulation targets and/or
stimulation protocols should be developed and applied
for IP and AP. Various techniques are available, as briefly
reviewed in the following.
B. Invasive neuromodulation
It is worthwhile to note that patients with chronic pain
syndromes—but headache-free—developed headaches
with migrainous features following implantation of deep
brain stimulation (DBS) electrodes that target in peri-
aqueductal grey (PAG)47,48. This was taken as evidence
for the significant role of PAG in the migraine generator
(see Sec. II, cf. Ref.7). Although posterior hypothalamic
DBS is applied to cluster headache, DBS as an invasive
method does not play a significant role in headache treat-
ment to date. The 3% risk of bleeding is only within the
upper range reported for DBS in movement disorders and
other than in these disorders (cf. Refs.49,50), the mode
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of action remains unclear for headache. In fact, even
placebo has not been conclusively ruled out46.
Therefore, current development efforts are primarily
on minimally invasive, and noninvasive (see below) neu-
romodulation. In IP, the sphenopalatine ganglion (SPG,
Sec. II D) plays a central role, therefore minimally inva-
sive sphenopalatine ganglion stimulation might be suited
in particular in this phase. An implantable battery-free
SPG stimulator has been developed to apply on-demand
stimulation for the treatment of migraine and other pri-
mary headache51. In a pilot study (n=11), the potential
of electrical stimulation of the SPG has been shown, 2
patients were pain-free within 3 minutes of stimulation,
3 had pain reduction, 5 had no pain relief, 1 was not
stimulated52. However, in this pilot study, the headache
was allowed to intensify up to 6 hours before stimula-
tion was initiated, which means that mode of action is to
be considered in the AP paradigm, where SPG probably
takes a less direct influence, see Fig. 8b.
A promising target is the TCC in both AP and IP.
With occipital nerve stimulation (ONS), the superior cer-
vical spinal cord of the TCC is accessible with minimally
invasive peripheral neuromodulation. Subcutaneously
(beneath skin) placed electrodes that start at the level of
C1 and transverse to C3 affect the corresponding occip-
ital nerve53,54. ONS is currently tested55,56. To develop
therapeutic strategies depending on a specific mode of
action in ONS, quantitative approaches for the migraine
generator have to be further developed to understand
how the facilitated pain traffic during central sensitiza-
tion (Fig. 8b) can be influenced via the ophthalmic divi-
sion of the trigeminal nerve.
C. Noninvasive neuromodulation
Transcutaneous and transcranial stimulation are the
two noninvasive modes. Transcutaneous electrical nerve
stimulation (TENS) modulates neural activity by tar-
geting noninvasively peripheral nerves (cf. ONS). In mi-
graine, a supraorbital transcutaneous stimulation (STS)
was tested with a portable device that looks like a sil-
ver headband and targets the ophthalmic division of the
trigeminal nerve—the first-order neuron that ends in the
TCC. The stimulation was tested with biphasic rectan-
gular AC impulses at 60Hz. The therapeutic gain (26%)
is within the range of those reported for other preven-
tive drug and nondrug antimigraine treatments57. But
like with ONS, the mode of action or even quantitative
methods to test paradigms are currently missing, though
it seems suggestive that if central sensitization of second-
order neurons are causing the pain, this method is sup-
pressing not the sensitivity to noxious stimuli or non-
noxious stimuli but the inbound sensory traffic.
Transcranial stimulation targets the cortex. Two non-
invasive neuromodulation techniques are available in mi-
graine, transcranial magnetic stimulation (TMS) and
transcranial electrical stimulation (TES). A carefully
sham-controlled larger trial with a portable TMS devise
was undertaken as a promising noninvasive neurostim-
ulator for disrupting migraine attacks58. The simplest
technology with the least safety issue is probably TES, a
method that therefore might pave the road for noninva-
sive portable devices for episodic migraine in less disabled
patients in the future. Two TES versions exist, transcra-
nial direct current stimulation (tDCS) and alternating
current stimulation (tACS). The lack of spatial specificity
is, however, a critical point. Cathodal tDCS inhibits,
anodal tDCS increases neuronal firing. Preliminary evi-
dence was found for patients with chronic migraine hav-
ing a positive, but delayed, response to tDCS applied to
motor (anodal) and oribitofrontal (cathode) cortices59.
Computational simulations of current flow through brain
regions were used to interpret the effects. With the help
of such simulations, a principal understanding of pain
modulation can be gained, whether this modulation is
due to the effect of TES on SD or on the dynamics of
the pain matrix (in chronic pain). Furthermore, the ef-
fect of TES on deeper structures beyond the immediate
cortical target regions can be estimated, including the
cingulate, insula, thalamus, and brainstem59. This is a
clinical research model that could serve as a guide to
future investigations. Effective prophylactic therapy in
migraine was also studied with cathodal tDCS over the
visual cortex with the anode overlying the motor and
sensory cortices60. When alternating current (AC) is ap-
plied over the scalp it is known as tACS, but tACS has
not been clinically tested in migarine.
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D. Model-based control
The above mentioned techniques need a model of the
pathophysiological events in the target region to optimize
the stimulation protocol. This is even mandatory in a
closed loop feedback control, such as a Kalman filter,
but it is also important for open loop control, which is
the current mode in all neuromodulation for migraine.
Simply said, given that we know how the hardware can
interface with the wetware, what is the best software?
Quantitative models for SD are already developed in
great detail. Not only macroscopic models are available,
such as suggested and briefly introduced here, but also
detailed models including the electrophsiological events
on a cellular level, for a review see Ref.61. This opens up
a model-based approach to target SD in the cortex.
Macroscopic equations of motion for SD, as Eqs. (1)-
(2)—which also are considered as “toy models”—have
two advantages. First, they allow extensive computa-
tional simulations of spatio-temporal pattern that extend
in the case of SD in migraine over several centimeters and
last up to one hour. A microscopic model of SD describ-
ing the dynamics on the millisecond scale of single cells
to calculate the noxious signatures that are transmitted
into the meninges during one hour over several square
centimeters is to crack a nut with a sledgehammer. How-
ever, the main advantage of such generic models lies in
the fact that they allow insight in the phase space struc-
ture of the whole class of models they represent, Fig. 4.
In this sense they are generic and well suited in particular
to develop open loop control stimulation protocols.
Given the predicted spatio-temporal signatures follow-
ing from the model in Eq. (1)-(2), stimulation protocols
in the ignition phase and the acute phase have different
control aims. The acute phase can be further subdivided
into one with the aura present and one with only the
headache. Furthermore, the prodromal phase exists.
The most obvious stimulation protocol can be derived
for the acute phase with the aura present. In this phase
the slow dynamics are governed by ghost behavior after
a saddle-node bifurcation, Fig. 4d. Noise can speed up
the transition time in this case and shorten the aura.
Although this is not the major contribution to the pain
phase as SD is below the pain threshold, once this thresh-
old is crossed during ignition, it is likely beneficial to
suppress any further release of noxious or inflammatory
mediators by the decaying SD wave.
According to our prediction, the most critical phase is
the ignition phase. In this phase the pain threshold will
be usually crossed. It is also the shortest lasting phase of
only a couple of minutes. This phase is therefore likely to
be missed, if neuromodulation is not used in a closed-loop
control with some sort of feedback.
Therefore, the prodromal phase becomes in particu-
lar valuable for prophylactic protocols. In this phase,
cortical excitability might be temporally decreased to
lower the upcoming ignition. Prophylactic protocols with
cathodal transcranial direct current stimulation of the
visual cortex are currently tested60. Similar approaches
should be tested with TMS, which can be more spatially
selective to interact with cortical hot spots as targets.
In the acute pain phase, SD is not a target anymore.
Therefore the model contributes nothing to this phase,
except, as already noted above, that according to the
proposed mechanism transcutaneous stimulation will in
this case target the inbound sensory traffic.
V. SUMMARY
The migraine generator (Sec. II) and the spreading de-
pression (Sec. III) theory of migraine are not mutually
exclusive theories of the cause of episodic migraine. Suf-
ficient evidence speaks to the fact that both theories can
be validly maintained. It may be that the migraine sub-
types MWoA and MWA have different pathophysiological
mechanisms, though this seems rather unlikely. Likewise,
it cannot be ruled out that the phenotype of each classi-
fication subtype has different pathophysiological mecha-
nisms.
The proposed mechanism still allows space for either
of these possibilities. The unified framework, however,
does not rely on either of these options. We propose that
stereotype spatio-temporal signatures of SD (Fig. 5) can
selectively drive rhythms in the MGN, which in turn is
part of a larger network (Fig. 2) that controls the spatio-
temporal dynamics of SD in the first place.
The question of the most upstream events in episodic
migraine lead to a long standing controversy. To my
mind, the settlement of this controversy points strongly
to the need to complement clinical and experimental
data with quantitative approaches, in particular com-
putational simulations and mathematical analysis of the
dynamical interaction between the migraine generator
and spreading depression. This study can only outline
a framework for such quantitative approaches.
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